By Karlee Weinmann ( December 7, 2012, 1:54 PM EST) -- Carlyle Group LP-backed Claris Lifesciences Ltd. will sell 80 percent of its emerging-markets infusions business to a pair of Japanese companies for $194 million, forming a three-way joint venture to ramp up new product innovation and output, Claris said Friday....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.